Discovery of cells that keep immune responses in check wins medicine Nobel Prize

On Monday, Mary Brunkow, Fred Ramsdell, and Shimon Sakaguchi were honored with the 2025 Nobel Prize in Physiology or Medicine for their groundbreaking discovery of a unique subset of immune cells. These specialized regulatory T cells play a crucial role in maintaining immune balance by preventing harmful autoimmunity and excessive responses to pathogens. The significance of regulatory T cells lies in their ability to mediate peripheral immune tolerance. This process allows the immune system to respond appropriately to foreign threats while avoiding attacks on the body's own tissues. Prior to the research conducted by the awardees, it was commonly believed that immune tolerance was primarily established in the thymus, the central organ responsible for T cell maturation. In the thymus, T cells are rigorously tested to ensure they do not target the body's own components, which could lead to autoimmune diseases. During this maturation process, T helper cells and T killer cells are developed, each with distinct roles in immune responses. T helper cells activate immune responses against intruders, while T killer cells eliminate infected or cancerous cells. The thymus employs a unique mechanism to test T cells by presenting them with body-derived antigens. If a T cell binds to one of these targets, it indicates a potential for autoimmune reactions, prompting its elimination. However, researchers suspected that additional regulatory mechanisms existed beyond the thymus, capable of managing T cells that had evaded central tolerance. These insights into peripheral regulation were initially proposed in the 1970s with the concept of "suppressor T cells," but the idea faced skepticism due to conflicting data. The work of Brunkow, Ramsdell, and Sakaguchi has now validated the existence and importance of these regulatory mechanisms, reshaping our understanding of immune system function and tolerance.